on Bloomberg Radio, about the Pfizer – Medivation deal

Link: http://www.bloomberg.com/news/audio/2016-08-22/the-bloomberg-advantage-gordon-on-pfizer-deal-for-medivation

——————–

Pfizer pays $14 billion to acquire an entrepreneurial company with a
successful cancer product that the company took all the way to market.

I am congested thanks to allergies.

http://www.bloomberg.com/news/audio/2016-08-22/the-bloomberg-advantage-gordon-on-pfizer-deal-for-medivation


_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

Leave a comment